Variant report

Variant	nsv574465
Chromosome Location	chr17:15787087-15793443
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:7)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:7 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr17:15791535..15794057-chr17:15795691..15797755,2	MCF-7	breast:
2	chr17:15788370..15791029-chr17:15792412..15794241,3	MCF-7	breast:
3	chr17:15780272..15782424-chr17:15786424..15788157,2	K562	blood:
4	chr17:15791472..15794195-chr17:15796023..15798848,3	K562	blood:
5	chr17:15786537..15789462-chr17:15796062..15797687,2	MCF-7	breast:
6	chr17:15788370..15791029-chr17:15792412..15794241,3	MCF-7	breast:
7	chr17:15787293..15789868-chr17:15796195..15798125,2	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ZSWIM7-7	chr17:15788959-15789222	predAs_ge08_ADORA2B_1

No data

Extended variants
information (count: 218 )
Associated
traits (count: 128 )

Variant overlapped rSNPs/rCNVs (count:218 , 50 per page) page: 1 2 3 4 5

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs1797463	chr17:15787087-15787088	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs116283667	chr17:15787156-15787157	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs561659101	chr17:15787163-15787164	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs181548723	chr17:15787215-15787216	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs186157404	chr17:15787216-15787217	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs564648557	chr17:15787219-15787220	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs142311617	chr17:15787320-15787321	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs190133287	chr17:15787323-15787324	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs567084434	chr17:15787343-15787344	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs572290157	chr17:15787345-15787346	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs181296769	chr17:15787362-15787363	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs28680408	chr17:15787373-15787374	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs577004189	chr17:15787378-15787379	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs537850516	chr17:15787452-15787453	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs568133805	chr17:15787458-15787459	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs557191017	chr17:15787498-15787499	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs185932049	chr17:15787514-15787515	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs539755255	chr17:15787571-15787572	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs563045990	chr17:15787623-15787624	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs35621066	chr17:15787633-15787634	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs10714705	chr17:15787711-15787712	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs573116024	chr17:15787719-15787720	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs146034548	chr17:15787742-15787743	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs190753709	chr17:15787746-15787747	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs575285780	chr17:15787747-15787748	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs541781420	chr17:15787809-15787810	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs8072473	chr17:15787814-15787815	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs139956192	chr17:15787891-15787892	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs533438690	chr17:15787895-15787896	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs542315326	chr17:15787922-15787923	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs540971986	chr17:15787924-15787925	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs112301146	chr17:15787937-15787938	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs141824965	chr17:15787944-15787945	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs150779982	chr17:15787966-15787967	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs139142184	chr17:15787976-15787977	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs55926306	chr17:15788017-15788018	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs551468264	chr17:15788066-15788067	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs561767937	chr17:15788094-15788095	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs571013821	chr17:15788096-15788097	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs183050971	chr17:15788108-15788109	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs115121100	chr17:15788110-15788111	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs527944589	chr17:15788141-15788142	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs188705636	chr17:15788150-15788151	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs150021912	chr17:15788254-15788255	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs145222133	chr17:15788256-15788257	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs140721113	chr17:15788290-15788291	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs373499884	chr17:15788312-15788313	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs113828715	chr17:15788395-15788396	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs192353073	chr17:15788471-15788472	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs544324551	chr17:15788494-15788495	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:128)

Disease	PMID	Source
Burkitt''s lymphoma	18698080	CNVD
Breast cancer	17603634	CNVD
Melanoma	18172304	CNVD
Glioblastoma multiforme	19435819	CNVD
Non-small cell lung cancer	19010865	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Colorectal cancer	16774939	CNVD
Hepatocellular carcinoma	18803288	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Burkitt''s lymphoma	19759907	CNVD
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Chordoma	21602918	CNVD
Miller-Dieker syndrome	22283845	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Cancer	22429812	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Ewing''s sarcoma	21437220	CNVD
Follicular lymphoma	19010834	CNVD
Colorectal cancer	20709793	CNVD
Acute myeloid leukemia	16864856	CNVD
Endometrial cancer	22040021	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Breast cancer	22028636	CNVD
Breast cancer	20837533	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
colon cancer	17210682	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Chronic lymphocytic leukemia	17971485	CNVD
Basal cell lymphoma	17170743	CNVD
Breast cancer	16461572	CNVD
Colorectal cancer	16272173	CNVD
Follicular lymphoma	17170743	CNVD
Human rectal carcinomas	16397240	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20724749	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Acute myeloid leukemia	17237825	CNVD
Colorectal cancer	21645411	CNVD
HIV/AIDS	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
HIV/AIDS	17953491	CNVD
HIV/AIDS	20877625	CNVD
Immune disease	21076436	CNVD
Rheumatoid arthritis	17953491	CNVD
Type 1 diabetes	17953491	CNVD
HIV/AIDS	15637236	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Neurofibromatosis	18196300	CNVD
Adenoid cystic carcinoma	18332873	CNVD
Multiple myeloma	16616336	CNVD
Multiple myeloma	17550852	CNVD
Pancreatic cancer	21811587	CNVD
Autism	17322880	CNVD
Hereditary neuropathy with liability to pressure palsy	19521722	CNVD
Schizophrenia	19571808	CNVD
Schizophrenia	19955444	CNVD
Charcot-marie-tooth disease	18787571	CNVD
Breast cancer	20409316	CNVD
Autism	18414403	CNVD
Breast cancer	17001317	CNVD
Rhabdomyosarcoma	16790082	CNVD
Myelofibrosis	22110671	CNVD
Peripheral neuropathy	21193943	CNVD
Schizophrenia	20587603	CNVD
Schizophrenia	22958593	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Ovarian cancer	20844748	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Charcot-marie-tooth disease	16463004	CNVD
Osteosarcoma	22292074	CNVD
Charcot	16760730	CNVD
Mental retardation	17901693	CNVD
ovarian endometriomas	16273235	CNVD
Breast cancer	21858162	CNVD
Ovarian cancer	21720365	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	17142309	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Autism	22102821	CNVD
Gastric cancer	18160780	CNVD
early-passage human iPS cells	21368824	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:79 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:15782600-15799000	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
2	chr17:15784200-15790400	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
3	chr17:15784800-15787200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
4	chr17:15785600-15787600	Enhancers	HSMMtube	muscle
5	chr17:15785800-15787600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
6	chr17:15785800-15790000	Weak transcription	Fetal Muscle Leg	muscle
7	chr17:15786400-15789200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
8	chr17:15786400-15789200	Weak transcription	NHDF-Ad	bronchial
9	chr17:15786400-15790200	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
10	chr17:15786800-15788000	Enhancers	Primary monocytes fromperipheralblood	blood
11	chr17:15786800-15790000	Enhancers	Monocytes-CD14+_RO01746	blood
12	chr17:15787000-15787600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
13	chr17:15787000-15787600	Enhancers	Primary hematopoietic stem cells short term culture	blood
14	chr17:15787200-15787400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
15	chr17:15787200-15787600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
16	chr17:15787200-15790200	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
17	chr17:15787400-15787600	Enhancers	K562	blood
18	chr17:15787400-15788200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
19	chr17:15787600-15789200	Weak transcription	Primary hematopoietic stem cells short term culture	blood
20	chr17:15787600-15790200	Weak transcription	HMEC	breast
21	chr17:15787600-15794000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
22	chr17:15787600-15795800	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
23	chr17:15787600-15796200	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
24	chr17:15788000-15789200	Weak transcription	Primary monocytes fromperipheralblood	blood
25	chr17:15788000-15789200	Weak transcription	K562	blood
26	chr17:15788200-15788400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
27	chr17:15788400-15789200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
28	chr17:15789000-15789600	Enhancers	HUVEC	blood vessel
29	chr17:15789000-15790800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
30	chr17:15789200-15789400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
31	chr17:15789200-15789600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
32	chr17:15789200-15789600	Enhancers	NHDF-Ad	bronchial
33	chr17:15789200-15790400	Enhancers	GM12878-XiMat	blood
34	chr17:15789200-15790600	Enhancers	K562	blood
35	chr17:15789200-15791000	Enhancers	Primary monocytes fromperipheralblood	blood
36	chr17:15789200-15791000	Enhancers	Primary hematopoietic stem cells short term culture	blood
37	chr17:15789200-15791000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
38	chr17:15789400-15789600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
39	chr17:15789400-15790600	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
40	chr17:15789400-15796000	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
41	chr17:15789600-15790000	Enhancers	NHEK	skin
42	chr17:15789600-15790400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
43	chr17:15789600-15790800	Enhancers	Primary hematopoietic stem cells	blood
44	chr17:15789600-15790800	Enhancers	Primary T killer naive cells fromperipheralblood	blood
45	chr17:15789600-15796200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
46	chr17:15789800-15790600	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
47	chr17:15789800-15790600	Enhancers	Fetal Muscle Trunk	muscle
48	chr17:15789800-15791000	Enhancers	Primary T helper cells fromperipheralblood	blood
49	chr17:15790000-15790400	Enhancers	Primary T helper naive cells fromperipheralblood	blood
50	chr17:15790000-15790600	Enhancers	Primary T helper naive cells from peripheral blood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links